Valeant Pharmaceuticals North America
- ACETAMINOPHEN CODEINE PHOSPHATE VALEANT oral suspension 12 mg/5 ml+120 mg/5 ml
- ANCOBON capsule, hard 250 mg
- ANCOBON capsule, hard 500 mg
- ATIVAN tablet 0.5 mg
- ATIVAN tablet 1 mg
- ATIVAN tablet 2 mg
- CARAC cream 0.5%
- EFUDEX cream 5%
- EFUDEX cutaneous solution 2%
- EFUDEX cutaneous solution 5%
- ERTACZO cream 2%
- INFERGEN solution for injection 15 µg/0.5 ml
- INFERGEN solution for injection 9 µg/0.3 ml
- ISORDIL TITRADOSE tablet 40 mg
- ISORDIL TITRADOSE tablet 5 mg
- KLARON cutaneous emulsion 10%
- MEPHYTON tablet 5 mg
- MESTINON prolonged-release tablet 180 mg
- MESTINON syrup 60 mg/5 ml
- MESTINON tablet 60 mg
- MYSOLINE tablet 250 mg
- MYSOLINE tablet 50 mg
- PENLAC medicated nail lacquer 8%
- PHRENILIN capsule, hard 650 mg+50 mg
- PHRENILIN tablet 325 mg+50 mg
- RENOVA cream 0.02%
- RETIN A cream 0.025%
- RETIN A cream 0.05%
- RETIN A cream 0.1%
- RETIN A gel 0.01%
- RETIN A gel 0.025%
- RETIN A MICRO gel 0.04%
- RETIN A MICRO gel 0.08%
- RETIN A MICRO gel 0.1%
- TARGRETIN capsule, soft 75 mg
- TARGRETIN gel 1%
- TIAZAC prolonged-release capsule, hard 120 mg
- TIAZAC prolonged-release capsule, hard 180 mg
- TIAZAC prolonged-release capsule, hard 240 mg
- TIAZAC prolonged-release capsule, hard 300 mg
- TIAZAC prolonged-release capsule, hard 360 mg
- TIAZAC prolonged-release capsule, hard 420 mg
- TRETINOIN VALEANT gel 0.05%
- VASERETIC tablet 10 mg+25 mg
- VASOTEC tablet 10 mg
- VASOTEC tablet 2.5 mg
- VASOTEC tablet 20 mg
- VASOTEC tablet 5 mg
- VIRAZOLE powder for nebuliser solution 6 g
- XERESE cream 5%+1%
- ZELAPAR oral lyophilisate 1.25 mg
- ZOVIRAX cream 5%
- ZOVIRAX ointment 5%